CM
PAHC icon

Castleark Management’s Phibro Animal Health PAHC Stock Holding History

Castleark Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-142,900
Closed -$7.9M – 338
2026
Q1 		$7.9M Buy
+142,900
New +$6.8M 0.26% 93

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Castleark Management's PAHC Position: Q2 2026 in Review

Castleark Management sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 142,900 shares — an estimated $7.9M sold.

Castleark Management first reported a position in PAHC in Q1 2026 and held it in 1 quarter. The position peaked at $7.9M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Castleark Management reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Castleark Management sold 142,900 Phibro Animal Health shares in Q2 2026, an estimated $7.9M.
  • Castleark Management first reported a position in Phibro Animal Health in Q1 2026 and held it in 1 quarter.
  • Castleark Management's Phibro Animal Health position peaked at $7.9M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Castleark Management's 13F filing for Q2 2026, filed 14 Aug 2026.